David Stone 5/11/23 David Stone 5/11/23

BioNTech's Hesitance and Matinas BioPharma's Persistence: A Study in Risk Tolerance

Isha Tanaka 5/2/23 Isha Tanaka 5/2/23

Trojan Horse Drug Delivery: The Future of Medicine and Matinas BioPharma's LNC Technology

Mark Armstrong 5/1/23 Mark Armstrong 5/1/23

The Potential of Matinas BioPharma’s Lipid Nano-Crystal Technology in Drug Development

David Stone 4/24/23 David Stone 4/24/23

Is BioNTech About to Take a Major Stake in Matinas BioPharma?

Mark Armstrong 4/20/23 Mark Armstrong 4/20/23

Could the Next Pandemic Be Fungal-Based?

GripRoom Research 4/23/22 GripRoom Research 4/23/22

Matinas BioPharma - Insightful social media posts and due diligence

David Stone 3/19/22 David Stone 3/19/22

Growth Stocks are Back on the Menu as Fears of WW3 Fade